Evidence-Based Update on Crohn’s Disease

Post Test

A score of 70% must be achieved to receive continuing education credits.

1. Crohn’s disease (CD) mainly affects people between the ages of 15 and 35.
 True
False
2. In retrospective studies, 25% of patients accounted for 80% of the total charges.
 True
False
3. Characteristics of moderate Crohn’s disease include:
a. No symptoms outside the digestive tract
b. Frequent loose to liquid bowel movements daily with blood in stool
c. Abdominal pain
d. Systemic symptoms of inflammation
e. All of the above
4. There are 3 drugs approved for treating Crohn’s disease.
True
False
5. Most patients with CD will eventually develop a stricturing or a perforating complication.
True
False
6. Conventional therapies include
a.Antibiotics
b. Corticosteroids
c. Budesonide
d. Aminosalicylates
e. Surgery
f, Immunosuppressants
g.All of the above
7.  Evaluation of treatment success in the Top-Down/Step Up Therapy showed the difference in top down and step up groups in immunosuppressant use began to narrow after 60 weeks
True
False
8 Infliximab was the first biologic approved for the treatment of CD
True
False
9 Post analysis of ACCENT 1 data showed overall efficacy was better with scheduled strategy of infliximab than episodic treatment.
True
False
10 Accent II trials showed 77% of patients had lost treatment response within 24 months of initiation of therapy.
True
False
11 Adalimumab, a fully human anti-TNF, has FDA indications for patients if they have lost response to or are intolerant to infliximab.
True
False
12 Future biologic therapies include:
a. Innate immunity activators
b. Adhesion molecule inhibitors
c. Th-1 polarization inhibitors
d. Anti-inflammatory cytokines receptors
e. All of the above

 

Activity Evaluation

Please rate this activity on the following scale:
4 - Excellent        3 - Good        2 - Fair        1 - Poor

Activity met my expectations    4        3        2        1  
Activity was free of bias    4        3        2        1
Activity content was understandable    4        3        2        1
Presenter was free of bias    4        3        2        1
Method of learning was beneficial    4        3        2        1


Due to the content of this activity, I will change my practice patterns by:

Reviewing current plan guideline for the treatment of Crohn's Disease
Providing appropriate education on the importance of case management in treating CD
Identifying patients for appropriate treatments to improve remission rates
My practice patterns will not change

Continuing education implies quality improvement in behavior. As part of our quality improvement process, NAMCP/AAMCN will contact you 6 months from your post test submission to monitor change.


Name:  
Profession: MD  DO  RN  Other:
Mailing Address:  
City, State, Zip:  
Phone:  
Fax:  
Email:  
Heard About Activity By: eNews  Journal  Colleague  Internet
Send my certificate by: U.S. Mail             Email